Fig. 7: The mechanistic scheme of a dual functionalized BIP-MPC-NP in temozolomide-resistant glioma.

The mechanistic scheme of BIP-MPC-NP attenuating DNA damage repair to enhance TMZ sensitivity by simultaneously mitigating EGFR and MET activation in TMZ-resistant gliomas.